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ABSTRACT 
 
 
The HIV/AIDS still remains a global health challenge with 42 million people infected 
with the virus. An alarming 70% of these people reside in sub-Saharan Africa with 
HIV-1 subtype C being the most prevalent subtype in this region and globally. HIV-1 
protease (PR) is an obligate homodimer which plays a pivotal role in the maturation 
and hence propagation of the HI virus. Although successful developments on PR 
active site inhibitors have been achieved, the major limiting factor has been the 
emergence of HIV drug resistant strains. It has been postulated that 
disruption/dissociation of the dimer interface may lead to an inactive enzyme. The 
development of small molecules and peptides has been a major research area with the 
key target being the N- and C-termini antiparallel β-sheet. This is due to its highly 
conserved nature and because it consists of a cluster of amino acids that contribute 
most of the binding energy and stability of the dimer interface. Hence it is referred to 
as a ‘hot-spot’. Therefore, binding of protease inhibitors at this site could cause 
destabilisation and/or dissociation of the enzyme. The terminal residue, F99, was 
mutated to an alanine disrupting the presumed lock-and-key motif it forms and in turn 
creating a cavity at the N- and C-termini antiparallel β-sheet. A second mutant, 
W42F/F99A, was created for monitoring tertiary structural changes exclusively at the 
N- and C-termini antiparallel β-sheet. The F99A and W42F/F99A, compared to the 
wild-type, showed a higher expression yield and also migrated further when separated 
using tricine SDS-PAGE. Wild-type protease CD spectra showed a minimum at 214 
nm and a local maximum at 230 nm, while the mutants exhibited minima at 203 nm 
and absence of the local maxima. A 50% higher fluorescence intensity and a 2 nm 
red-shift for the mutants versus the wild-type was observed. According to SE-HPLC 
data the relative molecular weight of the wild-type, F99A and W42F/F99A are 16.4 
kDa, 20.7 kDa and 18.1 kDa, respectively. Although the thermal unfolding of all three 
proteases was irreversible, the unfolding transition of the wild-type was clearly 
defined between 55 °C and 63 °C. The F99A and W42F/F99A unfolding curves were 
linear without clearly defined transition states. The specific activity of the F99A 
(0.13 µmol/min/mg) amounted to a ten-fold reduction compared to the wild-type 
(1.5 µmol/min/mg). The substrate binding affinity (KM) for the F99A was 41% lower 
than the wild-type when 2 µM of protein was used.  
 iv 
The Vmax and kcat values were about 30-fold and two-fold, respectively, higher for the 
wild-type when compared to the F99A. Therefore, the tricine SDS-PAGE analysis, 
secondary and tertiary structural characterisation and thermal denaturation curve 
showed that the F99A mutation has altered the structure causing ‘partial’ unfolding of 
the protein. But, the protein still maintained minute activity. The overlap between the 
ANS binding spectra of the wild-type and variants suggests that the dimeric form still 
exists. 
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CHAPTER 1 INTRODUCTION 
1.1 HIV/AIDS 
 
Since its emergence in the 1980s, Human Immunodeficiency Virus has had a 
devastatingly massive and rapid infectious and fatality rate globally. HIV is a 
Lentivirus that has been shown to cause AIDS, a disease that causes about 1.9 million 
deaths annually (WHO, 2010; UNAIDS, 2009). About 42 million people in the world 
are HIV positive (Papathanasopoulos et al., 2003; UNAIDS, 2009) and more than 
70% of these infections occur in sub-Saharan Africa (UNAIDS, 2009). The HI virus 
is classified into different types, groups, subtypes, sub-subtypes and CRFs 
(Circulating Recombinant Forms) (Chakrabarti et al., 1987; Peeters et al., 1991; 
Osmanov et al., 2002). The two types, HIV-1 and HIV-2 are believed to originate 
from the SIVsm from the sooty mangabey monkey (Cerocebus atys) and the common 
chimpanzee (Pan troglodytes), respectively (Chakrabarti et al., 1987; Peeters et al., 
1991). Despite that they have emerged about the same time, HIV-1 is the most 
prevalent (Chakrabarti et al., 1987; Peeters et al., 1991). HIV-1 is further divided into 
group M (Major), O (outlier) and N (New or Non-M or Non-O), which are a 
consequence of cross-species transmission (Peeters et al., 1991).  
 
The genetic variability/distinction within group M has been mainly attributed to the 
HIV envelope glycoproteins giving rise to nine subtypes, A, B, C, D, F, G, H, J and 
K. The subtype B, which is widely spread in North America and Western Europe 
(Figure 1), has been the most studied. The manufactured HIV inhibitors are targeted 
against this subtype. In the sub-Saharan African region, subtype C is the most 
prevalent (Papathanasopoulos et al., 2003; Walker et al., 2005). Recently, studies 
have focused on subtype C, which accounts for 56% of infections worldwide (Walker 
et al., 2005). Amongst Southern African countries, South Africa is one of the most 
affected by this disease (Walker et al., 2005). A high prevalence of 35% in KwaZulu-
Natal, makes HIV one of the leading epidemics in the sub-Saharan Africa (Walker et 
al., 2005). 
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Figure 1. The global distribution of different HIV-1 subtypes  
The HIV-1 subtypes vary in their prevalence across the globe and within the African 
continent. The subtype B is mostly spread in North America and Europe, while the 
subtype C is more prevalent in sub-Saharan Africa. Picture was taken from 
http://www.pbs.org/wgbh/pages/frontline/aids/atlas/clade.htm. 
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1.2 HIV life-cycle and drug therapy 
 
The HI virus is approximately 100 to 120 nm in diameter and has a high replication 
rate, producing about 1010 virions daily (Greene, 1993; Coffin, 1995; Tavassoli, 
2011). HIV infection (Figure 2) commences when the gp120 of the viral envelope 
binds to the host CD4 receptor of the T-lymphocytes cells (Freed, 2001; Plantier et 
al., 2009). This is followed by the fusion step, which is mediated by the ternary 
complex comprising of the gp120, CD4 receptor and the co-receptor CXCR4. Once 
viral contents are released into the host cytosol, the single-stranded viral RNA is 
reverse-transcribed into double-stranded DNA by viral reverse transcriptase. This 
viral DNA enters the nucleus of the host-cell where it is ultimately integrated into the 
host genome by the viral enzyme, integrase. The recombinant DNA is then 
transcribed to mRNA which in turn is translated into viral Gag and Gag-Pol 
polyproteins (Freed, 2001; Mugnaini et al., 2005; Plantier et al., 2009). When the 
viral RNA and proteins have assembled, immature virions bud off. The last, but very 
crucial step (Kramer et al., 1986; Lambert et al., 1992), is maturation of the virus 
where the protease processes the Gag and Gag-Pol polyproteins producing a mature 
and infectious virus.  
 
The viral enzymes (reverse transcriptase, integrase and protease) are key targets for 
the development of HIV therapeutic drugs. Highly-active antiretroviral therapy 
(HAART), which is thus far, a well-established therapy, relies on a combination of 
three or more of these drugs (Broder, 2010). The solving of the first crystal structures 
of the HIV-1 Protease (Navia et al., 1989; Wlodawer et al., 1989; Weber, 1990) has 
enabled development of successful protease inhibitors, which target the protease 
active site. The FDA-approved  protease inhibitors include Amprenavir (APV), 
Atazanavir (ATV), Darunavir (TMC-114), Fosamprenavir (FOS-APV) Indinavir 
(IDV), Lopinavir (LPV), Nelfinavir (NFV), Ritonavir (RTV), Saquinavir (SQV) and 
Tipranivir (TPV) (Fitzgerald and Springer, 1991; Wlodawer and Vondrasek, 1998; 
Broder, 2010).  
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Figure 2. The HIV-1 life-cycle 
The HI virus gains entry into the host cell by binding to the host CD4 cell receptors 
via the virus gp120 (1, 2 and 3). The viral reverse transcriptase and integrase reverse 
transcribe the viral RNA into double-stranded DNA and integrate it into the host 
DNA, respectively (4 and 5). DNA transcription (6), followed by translation (7), 
occur prior to assembly (8) and maturation (9) steps. The 8th and 9th steps are critical 
and are carried out by the HIV protease. This figure was adapted from 
http://home.ncifcrf.gov/hivdrp/RCAS/replication.html. 
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These inhibitors impede the catalytic function of the enzyme, by preventing 
maturation and propagation of HIV. The NRTIs (nucleoside reverse transcriptase 
inhibitors) and NNRTIs (non-nucleoside reverse transcriptase inhibitors) target the 
reverse transcriptase, but with reduced efficiency in chronically infected cells 
(Lambert et al., 1992; Balzarini et al., 2005). This is because chronically infected 
cells are characterised by viral particles, which contain integrated proviral genome 
(Lambert et al., 1992; Balzarini et al., 2005). Therefore the reverse transcriptase is not 
needed in chronically-infected cells for production of new viral particles, hence 
targeting the RT is not as significant as targeting the PR for anti-viral drug 
chemotherapy. Protease inhibitors are efficient in both acutely and chronically 
infected cells, hence the protease is a more preferred target for rational drug design 
over the reverse transcriptase which is only effective in acutely infected cells (Kramer 
et al., 1986; Lambert et al., 1992).  
 
The emergence of HIV drug resistant strains and the genetic diversity of the virus 
have posed a major challenge in development of a durable anti-retroviral regimen and 
eradication of the virus from the host (Hoetelmans et al., 1997; Papathanasopoulos et 
al., 2003; Bannwarth et al., 2009). The lack of a proof-reading mechanism by the 
reverse transcriptase, drug-pressure and other factors promote mutations and selection 
of these drug resistant strains (Bebenek et al., 1989; Papathanasopoulos et al., 2003). 
One of the proposed attributes to resistance is the susceptibility of the protease to 
mutations. These mutations may alter catalysis by direct interaction with the inhibitor 
(flap mutations) or inducing conformational changes at the active site (hinge 
mutations) (Galiano et al., 2009). The altered conformation of the active site allows 
efficient substrate catalysis but still lowering the affinity of the protease to inhibitor 
(Galiano et al., 2009). Analysis of one of the first crystal structures of HIV-1 protease, 
led to the postulation that disruption/dissociation of the dimer interface may result in 
an inactive enzyme (Wlodawer et al., 1989). The dimer interface region; in particular 
the antiparallel β-sheet which is formed by the N- and C-termini has been identified 
as a potential drug-target. This owes to its highly conserved nature (Wlodawer et al., 
1989; Broglia et al., 2008; Bannwarth et al., 2009). Recently, the major focus has 
been on the development of novel peptides and small molecules that target this region 
so as to block dimerisation of the protease (Koh et al., 2007; Yan et al., 2008; 
Bannwarth et al., 2009).   
 6 
1.3 The common features and organisation of the dimer interface of proteins  
 
Protein dimer interfaces include the surface area buried upon dimerisation and 
residues that form inter-subunit interactions. Oligomerisation is an important 
phenomenon adopted by nature to reduce the protein surface area that is exposed to 
solvent (Jones and Thornton, 1995; Jones and Thornton, 1996; Tsai et al., 1997; Xu et 
al., 1997). Understanding of this phenomenon originates from early studies of 
haemoglobin and cytochrome c′ just to mention a few (Perutz et al., 1960; Finzel et 
al., 1985). This enables the protein to adopt a more spherical/globular form (Pace et 
al., 1996; Tsai et al., 1997; Chothia and Janin, 1975). This is important in the cell as it 
has an influence on molecular crowding. Like the HIV-1 protease, some proteins elicit 
functionality only when they have oligomerised. Most of these proteins rely on dimer 
interface interactions for complete stability and optimum functionality (Lancaster et 
al., 2004; Alves et al., 2006; Walton et al., 2009). For subunits to dimerise, they 
require specific recognition complementarity, which is dependent upon their physical 
shape and charge (Jones and Thornton, 1995).  
 
 
1.3.1 The physicochemical properties of the dimer interface 
 
It has been established that the recognition sites of proteins are predominantly 
hydrophobic, globular, and planar (Chothia and Janin, 1975; Tsai et al., 1997; Jones 
and Thornton, 1995). They also fold into shape and carry electrostatic groups that 
influence the complementarity of binding (Chothia and Janin, 1975; Tsai et al., 1997; 
Jones and Thornton, 1996). Generally, interactions at the dimer interface include salt-
bridges, hydrogen bonds, hydrophobic and van der Waals interactions (Chothia and 
Janin, 1975; Dill, 1990; Xu et al., 1997). The combination and magnitude of these 
interactions is unique for different proteins. The same principles that govern 
interactions for protein-protein interactions also apply to dimer interfaces (Janin and 
Chothia, 1990). A study reviewing the nature of protein-protein interactions (Janin 
and Chothia, 1990) showed that on average, the accessible surface area of a protein is 
rich with non-polar residues which populate about 55% to 75% of the total protein 
surface area (Janin and Chothia, 1990; Han et al., 2006).  
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The polar and charged residues form 25% and 20% of the accessible surface area, 
respectively (Janin and Chothia, 1990). Salt-bridges and hydrogen bonds can 
significantly enhance stability across the dimer interface but are mainly implicated in 
binding specificity (Janin and Chothia, 1990; Xu et al., 1997).  
 
Although hydrophobic interactions are mainly thought to drive dimerisation and also 
to stabilise the protein, they have been implicated in binding recognition (Keskin et 
al., 2005; Dill, 1990; Janin and Chothia, 1990). Upon interaction of subunits, packing 
of the respective side chains culminates in optimisation of the van der Waals 
interactions. This is very important in determining the surface shape complementarity 
of subunits (Janin and Chothia, 1990; Dey et al., 2010).  
 
The distribution of α-helices on protein surfaces and interfaces is constant. In contrast, 
the residues making up the β-strands are more likely to be found at interfaces versus 
the protein surfaces (Tsai et al., 1997). On the other hand, Jones and Thornton (1995) 
concluded that although all the structural elements are found at dimer interfaces, the 
helices predominate. The dimer interface residues when compared to residues in other 
regions of the protein make fewer intra-molecular contacts, making the dimer 
interface more flexible (Jones and Thornton, 1995).  
 
In contrast to the rest of the protein, the dimer interface exhibits a unique amino acid 
composition (Keskin et al., 2005). The aromatic groups are particularly favoured at 
the dimer interface because they provide good ‘glue’ for binding of subunits (Jones 
and Thornton, 1995). These residues tend to form, what is referred to as, a lock-and-
key motif where the aromatic side chain protrudes from one subunit and inserts/buries 
into the hydrophobic pocket of the other subunit (Jones and Thornton, 1995). This 
phenomenon has been well-documented for the glutathione S-transferases (GSTs) 
superfamily of proteins (Sayed et al., 2000; Alves et al., 2006; Parbhoo et al., 2011). 
1.3.2 Contribution of ‘hot-spots’ and conserved residues at the dimer interface 
 
Previously, Xu et al. (1997) suggested that the polar residues and hydrogen bonding 
groups are uniformly distributed throughout the dimer interface, implying equal 
contribution of the amino acid residues to the energy of stabilisation (Xu et al., 1997). 
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Despite that, a general amino acid pattern has not been established at dimer interfaces, 
hence the binding energy and stability contributed by amino acids is not uniform. That 
is, there maybe a single residue or a cluster of residues contributing more to the 
binding energy and stability of a protein. The amino acids that confer the most to 
binding energy and stability of the dimer interface are referred to as ‘hot-spots’ 
(Burgoyne and Jackson, 2006). These may occur as clusters that are surrounded by 
residues that contribute far less to the stability (Bogan and Thorn, 1998). Thus, 
residues that possess this feature make their identity, size and charge very important. 
Therefore, it only makes evolutionary sense that these ‘hot-spots’ and their 
neighbouring residues are conserved (Keskin et al., 2005). The tendency of conserved 
hot-spot residues to cluster, leads to the presumption that they could be useful in 
predicting their interacting partners (Caffrey et al., 2004; Burgoyne and Jackson, 
2006). But, it is also known that dimer interface residues are not any more or less 
conserved than other regions of the protein (Caffrey et al., 2004; Burgoyne and 
Jackson, 2006). 
 
 
1.4 The conformation of β-sheets and role at the dimer interface 
 
The amino acid side chains of the potential pairing β-strands are thought to play a role 
in recognition, proper folding conformation and hence stability of the resulting β-
sheet (Mandel-Gutfreund et al., 2001). The specificity with which β-strands recognise 
their pairing partners is still not clearly understood. This is because conservation of 
complementary strands is not drastically distinct from other non-binding β-strands. 
Also, the identity of pairing side-chains plays a minute role in binding recognition 
(Mandel-Gutfreund et al., 2001). However, it is understood that the identity of side-
chains may play a more important role when protein-protein binding is dependent on 
pairing of β-strands (Mandel-Gutfreund et al., 2001). Non-polar residues, similar to 
the protein core, are also more conserved in β-sheets (Mandel-Gutfreund et al., 2001). 
More specifically, the aromatic and β-branched amino acid pairs are more conserved, 
hence, they are more constrained to maintain hydrophobic interactions (Merkel et al., 
1999; Mandel-Gutfreund et al., 2001).  
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These, in turn, confer the most stability in β-sheets than other residues (Mandel-
Gutfreund et al., 2001). In particular, phenylalanine has high propensity for β-sheets 
and, in most part, is highly conserved when present in β-sheets. This aromatic residue 
has been implicated in the so called glycine ‘rescue’. This phenomenon involves the 
phenyl ring shielding the glycine amide and carbonyl groups from forming hydrogen 
bonds with the competing polar solvent (Mandel-Gutfreund et al., 2001; Merkel et al., 
1999). This, in turn, counteracts the destabilising effects of glycine (Merkel et al., 
1999).  
 
1.5 The structure and catalytic mechanism of HIV-1 protease 
 
The HIV-1 protease is described as an obligate homodimer because its functionality is 
dependent on the dimerisation of its symmetrical monomers (Hansen et al., 1988). 
These monomers, in turn, contribute two symmetrical aspartate residues at the single 
active site (Wlodawer and Gustchina, 2000). It, thus, belongs to the aspartic protease 
family; hence, it is also inhibited by pepstatin (Hansen et al., 1988; Wlodawer and 
Gustchina, 2000). The active site structural organisation is unique for retroviral 
proteases, and makes it different from the non-viral proteases. Each monomer of the 
HIV-1 protease is composed of 99 amino acids forming nine β-strands and one α-
helix (Figure 3). The prominent regions of this enzyme are the dimer interface, the 
flaps and hinge regions. The dimer interface is comprised of four regions: residues 1 – 
4 and 94 – 99, which form a four-stranded N- and C-termini antiparallel β-sheet; 
residues 24 – 29, with residues 25 – 27 (Asp25 - Thr26 - Gly27) forming the catalytic 
triad; residues 87, 90, 91, 92 and 93 which make up the α-helices and residues 48 – 54 
forming the flap tips (Weber, 1990; Coman et al., 2008b).  
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Figure 3. A ribbon representation of the dimeric structure of HIV-1 subtype C 
protease 
The α-helices of each monomer are in purple with the N- and C-termini antiparallel β-
sheet shown in red. The rest of the β-strands are represented in blue. The flap and 
hinge regions are also indicated. The catalytic triad residues (D25 – T26 – G27), from 
each monomer are coloured in orange. The C67 and C95 are yellow. The protease is 
complexed with Nelfinavir which is coloured green. Figure generated using PyMOL 
v0.99 (DeLano Scientific, 2006). PDB code 2R5Q (Coman et al., 2008b). 
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β-strand two to eight form a jelly-roll β-barrel topology within each subunit (Noel et 
al., 2009), whereas each α-helix anchors the N- and C-termini antiparallel β-sheet to 
the rest of the protease moiety (Louis et al., 2003). The active site, as previously 
mentioned, is positioned at the dimer interface and above it (Figure 3) the flaps are 
arranged such that they seem to enclose it from the environment. Consequently, for 
the substrate (inhibitor) to access the active site region, the flaps (residues 43 to 58) 
need to open up, and also to possibly exclude water molecules (Liu et al., 2008; 
Kozisek et al., 2008). The flaps are highly flexible and their flexibility is thought to be 
controlled by the hinges (Kozisek et al., 2008; Mosebi et al., 2008). Although the 
protease is symmetrical, its natural substrates are asymmetrical (Fitzgerald and 
Springer, 1991; Prabu-Jeyabalan et al., 2000). Binding of the substrate induces 
conformational changes which cause the monomers to assume a more asymmetrical 
arrangement (Prabu-Jeyabalan et al., 2000). Once the substrate has gained access to 
the active site, the D25/D25′ side-chain activates the conserved active site water 
molecule (Figure 4) which launches a nucleophilic attack on the carbonyl group of the 
polyprotein scissile bond. This is followed by protonation of the leaving amine group 
by the D25/D25′ residue resulting in hydrolysis of the polyprotein (Hansen et al., 
1988).  
 
Protease binding subsites are designated S1, S2, S3 and S1′, S2′, S3′ starting from the 
D25 residue. The S1 and S1′ subsites (similarly S2 and S2′ etc.) are contributed by 
each monomer at symmetric positions. The respective side-chains of the substrate are 
termed P1, P2, P3 and P1′, P2′, P3′ going toward the N-terminus and C-terminus, 
respectively (Wlodawer and Vondrasek, 1998; Prabu-Jeyabalan et al., 2000). The 
protease binding pockets comprise residues that form direct and indirect interactions 
with the substrate. These residues originate from different regions of the protease and 
either make direct and/or water-mediated hydrogen bonding, van der Waals and/or 
hydrophobic interactions with the substrate (Prabu-Jeyabalan et al., 2000). Therefore, 
substitution of these residues may directly alter the catalytic activity of the HIV-1 
protease by altering the binding affinity of substrate or inhibitor. 
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Figure 4. Schematic of scissile peptide bond hydrolysis by the aspartic protease 
One of the catalytic aspartate residues activates the conserved active site water 
molecule. The activated water molecule launches a nucleophilic attack on the 
carbonyl scissile peptide bond. The second aspartic acid residue then protonates the 
leaving amine group forming the acyl intermediate enzyme. The hydrolysis of the 
acyl enzyme is carried out by a water molecule thus completing the process of 
catalysis. The substrate side-chains are assigned by either P1 or P1′. Picture was 
adapted from http://www.jiaowu.buct.edu.cn/Courseware/Harvard/BCMP201/pdf/.  
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The flap region, with respect to its structural conformation, harbours significant 
differences amongst the retroviral proteases especially between the HIV-1 subtype A, 
B, C and F (Wlodawer and Gustchina, 2000). This region elicits drug resistance via 
residues at positions 46, 47, 48, 50, 53 and 54 (Liu et al., 2008; Galiano et al., 2009). 
 
HIV-1 subtypes harbour differences at the genetic and protein level and are called 
naturally occurring polymorphisms (NOPs) (Coman et al., 2008a). The NOPs that 
occur in the dimer interface are N88D, L89M and I93L, with L89M occurring in more 
than 95% of the subtype C strains. No major drug resistant mutations have been 
reported for the antiparallel β-sheet termini except for the conservative substitution, 
L97V. In other retroviral proteases, L97 is replaced by an isoleucine (Weber, 1990). 
This emphasises the importance of maintaining hydrophobic packing in the C- 
terminus (Louis et al., 2003; Bowman and Chmielewski, 2002).  
 
1.6 The N- and C-termini antiparallel β-sheet of HIV-1 protease: influence on 
structure, function and stability  
 
The N- and C-termini antiparallel β-sheet, often referred to as the dimer interface, is 
formed by four β-strands in retroviruses and by six β-strands in non-viral proteases 
(Wlodawer and Gustchina, 2000). Previous studies showed that the overall topology 
between rous sarcoma virus and HIV-1 proteases are similar (Wlodawer et al., 1989; 
Weber, 1990). Proteases from both viruses show significant intersubunit interactions 
in the “fireman’s grip” at the active site, between residues 8, 29 and 87 for HIV-1 and 
the N- and C-termini antiparallel β-sheet. The structural comparison between the two 
proteases also depicts the N- and C-termini β-strands arranged in a similar 
fashion (Wlodawer et al., 1989). The evolutionary conservation in the structural 
arrangement of this region suggests that it is crucial for maintaining the stability and 
function of the protease (Lesk and Chothia, 1980; Wlodawer et al., 1989; Mirny and 
Shakhnovich, 1999). Upon dimerisation, the HIV-1 protease subunits form a network 
of 34 hydrogen bonds and four ionic interactions between them. Two of these 
hydrogen bonds occur at the flaps, five at the active site residues and eight occurring 
between residues 6 – 8, 29 and 87. A substantial 19 hydrogen bonds and two ion pairs 
are formed at the N- and C-termini antiparallel β-sheet (Weber, 1990).  
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The C-terminal (residues 96 to 99) contributes 50% of subunit-subunit ionic and 56% 
hydrogen bond interactions and buries 45% of the surface area following dimerisation 
(Weber, 1990). Therefore, it is obvious that structure-based thermodynamic analysis 
showed that the N- and C-termini antiparallel β-sheet contributes about 75% to the 
total Gibbs energy (Todd et al., 1998). This region is, thus, a ‘hot-spot’. It was 
suggested that most of the energy of stabilisation at the N- and C-termini antiparallel 
β-sheet is mainly accounted for by interactions formed by residues F99, L97, N98, 
T96, C95, P1, I3 and L5 (Figure 5) (Todd et al., 1998). Notably, most of these 
residues are hydrophobic. The F99 residue contributes the most to the energy of 
stabilisation of the protease (Todd et al., 1998). This residue is oriented toward the 
interior of the dimer interface and is located in the presumed hydrophobic cleft which 
includes W6 (Hostomsky et al., 1989). The F99 locks into the hydrophobic pocket 
seemingly, with its phenyl ring facing and locking with P1 of the other subunit 
(Figure 6). P1 forms one inter-monomeric hydrogen bond with F99 (Coman et al., 
2008b). 
 
The F99 is conserved in HIV-1 and SIV (Simian Immunodeficiency Virus) proteases 
and a leucine is located at the position in HIV-2 and EIAV (equine infectious anaemia 
virus) proteases (Wlodawer and Gustchina, 2000). This implies that, not only do 
hydrophobic interactions drive subunit-subunit interactions but packing of these 
hydrophobic residues contributes significantly to the stability of the dimer (Louis et 
al., 2003; Bowman and Chmielewski, 2002). The N- and C-termini regions do not 
contribute directly to substrate binding nor does it partake directly in catalysis. The 
catalytic function of HIV-1 protease has been shown to be rather more sensitive to 
substitutions at the C-terminal residues than the N-terminal residues (Masso and 
Vaisman, 2003). But, both the N- and C-termini have been shown to be crucial for 
dimer formation and stability, especially the C-terminal (Louis et al., 2003; Ishima et 
al., 2003). Since HIV-1 protease is only active as a homodimer, the N- and C-termini 
therefore play an indirect but essential role in the function of the protease (Oroszlan 
and Luftig, 1990; Louis et al., 2003; Ishima et al., 2003). Previous studies have 
reported that the F99A mutation causes complete inhibition of the subtype B HIV-1 
protease (Pettit et al., 2003).  
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Figure 5. Monomeric HIV-1 protease colour coded according to residues that 
contribute to the stability of the dimer interface 
The F99 (black) contributes the most to Gibbs energy of stabilisation, followed by 
residues coloured red, orange, yellow, green and cyan, respectively. Those in blue do 
not contribute to the dimer interface. The picture was adapted from a study by Todd et 
al., 1998 and generated using PyMOL v0.99 (DeLano Scientific, 2006). PDB code 
2R5Q (Coman et al., 2008b).   
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Figure 6. The lock-and-key motif formed at the dimer interface of HIV-1 
protease 
The ‘key’ residue F99 (red) is inserted into the hydrophobic pocket (‘lock’) which is 
formed by the respective residues (cyan) from the partnering subunit. These residues 
are within 4 Å of F99. The phenyl ring of F99 and proline (Pro1) side-chain lock. The 
N98 (green) is from the same subunit as F99. The prime indicates residues from the 
partnering subunit. Figure generated using PyMOL v0.99 (DeLano Scientific, 2006). 
PDB code 2R5Q (Coman et al., 2008b). 
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Urea and thermal equilibrium unfolding/refolding studies done on subtype B HIV-1 
protease showed that the unfolding transitions followed a two-state mechanism given 
by the equation below (Todd et al., 1998; Noel et al., 2009). In contrast, the presence 
of a fully folded monomeric intermediate was detected by kinetic folding studies 
(Noel et al., 2009). The transient nature of the intermediate is due to the large 
hydrophobicity of the dimer interface, which makes it unstable when exposed to the 
solvent. Hence it is reported that the dimerisation step contributes the most Gibbs 
energy of stabilisation (Todd et al., 1998; Noel et al., 2009). The stability of the 
protease is both pH- and concentration-dependent, the latter being due to its dimeric 
nature (Todd et al., 1998; Noel et al., 2009). The protease is more stable at higher pH 
values, and at pH 5 the dissociation constant is in the micromolar range (Todd et al., 
1998; Noel et al., 2009). There is a knowledge gap on the unfolding mechanism for 
the South African subtype C HIV-1 protease. So far, the mechanism by which the 
protease dimerises within the Gag-Pol precursor in vivo, and the exact sequence of 
events that follow with respect to its cleavage and activation has not been elucidated. 
But it has been suggested that in vivo dimerisation and activation of the protease 
occurs whilst embedded within the Gag-Pol (Pettit et al., 2003). 
                                                   N2N2 ⇔                                                   Equation 1
 
 
 
Therefore, introducing mutations at highly conserved hydrophobic regions may result 
in destabilisation of the dimer and, hence, induce conformational changes at the active 
site, which may alter the function of HIV-1 protease homodimer (Broglia et al., 2008; 
Louis et al., 2003). The disruption of the N- and C-termini antiparallel β-sheet has 
also been a subject of rational drug design in other proteins, such as the amyloid 
fibrils responsible for Alzheimers disease and the adhesins from the bacterial pili 
responsible for uropathogenic infections (Li et al., 2006; Pinkner et al., 2006). 
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1. 7 Objective and aims 
 
The implication of regions near the active site in the rise of drug resistant mutations 
has led to development of novel ideas for inhibiting the HI virus. Highly conserved 
hydrophobic residues play an important role in the structure, function and stability of 
proteins (Lesk and Chothia, 1980a; Mirny and Shakhnovich, 1999). Previous studies 
have indicated that the N- and C-termini antiparallel β-sheet which forms part of the 
dimer interface is indispensable for dimerisation and stability of HIV-1 protease 
(Ishima et al., 2003; Ishima et al., 2007). Thus, the objective of this study is to detect 
residues at the dimer interface of HIV-1 subtype C protease that are required for HIV-
1 subtype C protease homodimeric structure, function and stability.  
 
The aims of this study are to: 
• Use sequence and secondary structural alignment bioinformatics tool to detect 
highly conserved residues at the dimer interface of South African HIV-1 
subtype C protease. 
• Employ PCR-based site-directed mutagenesis to generate the F99A mutation.  
• Compare the secondary, tertiary and quaternary structure of the mutant to the 
wild-type using far-UV circular dichroism, intrinsic and extrinsic fluorescence 
spectroscopy and SE-HPLC.  
• Investigate thermal stability by using far-UV circular dichroism.  
• Compare the activity of F99A and wild-type proteases by following the 
hydrolysis of a chromogenic substrate spectrophotometrically.  
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CHAPTER 2 EXPERIMENTAL PROCEDURES 
2.1 Materials 
 
The QuickChange® Lightning Site-Directed Mutagenesis kit was purchased from 
Stratagene (La Jolla, CA, USA). The synthesis of oligonucleotide primers and DNA 
sequencing was done by Inqaba Biotec (Pretoria, SA). Chromogenic substrate was a 
kind gift from Dr T. Govender from University of KwaZulu-Natal. The chromogenic 
substrate is a peptide with the sequence Lys-Ala-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-
Nle-NH2.  All the other chemicals were of analytical grade.  
 
2.2 The HIV-1 expression vector 
 
The pET-HIVPR plasmid encoding wild-type HIV-1 subtype B protease was a kind 
gift from Dr J. Tang, University of Oklahoma Health Science Centre, Oklahoma City 
(Ido et al., 1991). The South African subtype C HIV-1 protease, when compared to 
the B subtype protease, encodes the following polymorphisms; T12S, I15V, L19I, 
M36I, R41K, H69K, L89M and I93L. These polymorphisms, including the Q7K that 
minimises the autoproteolysis of the PR, were introduced into the pET-HIVPR 
expression vector by Dr. S. Mosebi (University of the Witwatersrand, Johannesburg). 
The expression vector will be referred to as pET-WTCSA encoding, the ‘wild-type’ 
HIV-1 subtype C SA protease.  
 
2.3 Engineering of primers and mutants using site-directed mutagenesis 
 
To construct the F99A and W42F/F99A mutants, specific oligonucleotide primers 
were designed based on the pET-WTCSA sequence (Dr Y. Sayed). The primers were 
designed based on the pET-WTCSA sequence using the Primer-X software 
(http://bioinformatics.org/primex). The primer sequences (Figure 7) were analysed 
using the Gene Runner software programme v3.01 (Hastings Software Inc., NY.USA) 
to check for possible formation of secondary structures.  
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Figure 7. Primer sequences of the F99A and W42F mutations  
Primer sequences for the construction of the F99A and W42F mutations are indicated. 
The codons for alanine and phenylalanine are in bold. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
F99A Fwd : 5' CAGCTGGGTTGCACTTTGAACGCGTAGTAATGTCCGATTGAAAT 3' 
F99A Rev  : 5' CATTTCAATCGGAGATTACTACCGCGTTCAAGTGCAACCAGCTG 3' 
 
W42F Fwd: 5' GAAATCAATCTGCCTGGTAAGTTCAAGCCTAAAATGATCGGTGGC 3' 
W42F Rev:  5' GCCACCGATCATTTTAGGCTTGAACTTACCAGGCAGATTGATTTC 3' 
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To generate both the F99A and W42F/F99A mutants, the QuickChange® Lightning 
Site-Directed Mutagenesis kit from Stratagene (Braman et al., 1996) was used. 
Briefly, the reactions were carried out at 95 °C to denature the double-stranded DNA 
for 30 seconds, followed by primer annealing at 55 °C for 60 seconds and then DNA 
elongation at 68 °C for 5 minutes. The PCR products were then digested with DpnI 
(10 U/µg DNA) restriction enzyme at 37 °C for an hour and then at 20 °C for another 
hour. The DpnI digests methylated DNA template (Nelson and McClelland, 1992; 
Chung et al., 1989). The digested products were then used to transform XL 10-Gold 
Ultra Competent E. coli cells (Stratagene). The transformation was carried out by the 
one-step method (Chung et al., 1989). Cells were then plated on Lysogeny Broth 
(LB)-agar plates (0.5% (w/v) yeast, 1% (w/v) tryptone, 1% (w/v) NaCl), 1.5% (w/v) 
agar)  supplemented with 100 µg/ml of ampicillin and incubated for 16 hours at 
37 °C. The plasmid DNA was extracted from cells using the Strataprep miniprep kit 
by following the manufacturer’s instructions (Stratagene, La Jolla, USA). 
Quantification and analysis of the plasmid DNA was performed by using the 
nanodrop spectrophotometer (Thermo Scientific). The plasmids encoding the F99A 
and W42F/F99A are referred to as pET-F99A-CSA and pET-W42F/F99A-CSA, 
respectively. See Table 1 for a summary of the PCR assays. 
 
2.4 Transformation of Escherichia coli T7 Express cells with plasmid DNA 
 
E. coli T7 Express Iq competent cells (New England Biolabs Inc., Ipswich, MA, USA) 
were transformed with either pET-WTCSA (10 ng), pET-F99A-CSA (10 ngl) or pET-
W42F/F99A-CSA (10 ng) plasmid. The cells were then plated on Lysogeny Broth 
(LB) agar plates supplemented with 100 µg/ml ampicillin and 35 µg/ml 
chloramphenicol to specifically select for transformed cells. The plates were 
incubated for 16 hours at 37 °C. Cell colonies which were successfully transformed 
were grown in LB medium (0.5% (w/v) yeast, 1% (w/v) tryptone, 1% (w/v) NaCl) 
supplemented with 100 µg/ml ampicillin and 35 µg/ml chloramphenicol. These cells 
were grown at 37 °C, shaking at 250 rpm for 20 hours. 
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Table 1: PCR-based mutagenesis assay preparation 
Mutagenesis was performed as described in section 2.3 using the reagents below: 
  
Reagent Volume (µl) Final concentration (ng/µl) 
 
10 × Reaction buffer 
 
5 - 
 
Forward primer 
 
1 
 
125  
 
Reverse primer 
 
1 
 
125 
 
Double-stranded DNA template 
 
4.8 
 
15  
 
QuickChange® dNTP mix 
 
1.5 - 
 
milliQ water 
 
36.7 - 
 
QuickChange® Lightning enzyme 
 
1 - 
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2.5 Over-expression and purification of HIV-1 protease  
 
HIV-1 PR was over-expressed as inclusion bodies (Ido et al., 1991) in Escherichia 
coli T7 Express cells. Cells were grown overnight in LB containing 100 µg/ml 
ampicillin and 35 µg/ml chloramphenicol at 37 °C. The culture was then diluted 
100-fold into fresh LB media and grown until an optical density (OD600 nm) of 0.4 – 
0.5. IPTG was then added to a final concentration of 0.4 mM to induce expression for 
4 hours at 37 °C. Cells were harvested by centrifugation at 5000 × g, and the pellet 
was resuspended in buffer A (10 mM Tris, 2 mM EDTA and 1 mM PMSF, pH 8) and 
then stored at -20 °C overnight. The thawed cells were sonicated following the 
addition of MgCl2 and DNase I to final concentrations of 10 mM and 10 U/µl 
respectively, and then centrifuged at 15 000 × g for 30 minutes. The resulting pellet 
was resuspended in ice-cold buffer A containing 1% (v/v) Triton X-100 and again 
centrifuged at 15 000 × g for 30 minutes. The inclusion bodies containing the 
recombinant HIV-1 protease and cell debris were collected by centrifuging at 
15 000 × g for 30 minutes at 4 °C. Finally, the pellet was resuspended in buffer B 
(10 mM Tris, 8 M urea and 2 mM DTT, pH 8) to solubilise the pellet. The solubilised 
pellet was passed through a column packed with diethylaminoethyl (DEAE) anion 
sepharose matrix, pre-equilibrated with buffer B. The Bradford assay reagent 
(Bradford, 1976) was used to identify protein-containing fractions, which were then 
pooled and acidified with formic acid to a final concentration of 25 mM. Acidification 
caused precipitation of non-aspartic protease contaminants (Ido et al., 1991). The 
protease was refolded by dialysis against 10 mM formic acid at 4 °C. The refolded 
protease was dialysed against protease storage buffer C (10 mM sodium acetate, 
1 mM NaCl and 2 mM DTT, pH 3.5). 
 
A further purification step was required to remove contaminating proteins. The 
carboxymethyl (CM) cation exchange column was equilibrated using buffer C. The 
refolded protease which was dialysed against buffer C was loaded onto the CM 
column which was washed using the same buffer to remove proteins which are bound 
non-specifically. The protease, bound to the column, was eluted using a salt gradient 
from 0 to 1 M NaCl. The pooled fractions were desalted and dialysed against 
buffer C. 
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2.6 Analysis of the purity of the proteases (wild-type, F99A and W42F/F99A) by 
tricine-SDS-PAGE 
 
Tricine-SDS-PAGE (Schagger and von Jagow, 1987; Schagger, 2006) was used to 
confirm the size and purity of the wild-type and mutants. The principle of this method 
is similar to glycine-SDS-PAGE (Laemmli, 1970), but in this case tricine is the 
trailing ion. This system is ideal for resolving proteins below 20 kDa because of its 
ability to separate these proteins from bulk SDS before reaching higher acrylamide 
concentrations (Schagger and von Jagow, 1987; Schagger, 2006). This is due to the 
higher pKa of tricine. This technique relies on the dodecyl group of the SDS to bind to 
hydrophobic regions of the protein while the sulfonate part gives the protein an 
overall negative charge. The respective protein denatures and adopts a rod-like shape 
with an overall negative charge. Therefore, the compactness and hence the abundance 
of hydrophobic amino acid influences SDS binding and migration of the SDS-protein 
complex on the acrylamide gel. 
 
Stacking and separating gels were prepared to a final concentration of 4% (w/v) and 
16% (w/v) acrylamide/bisacrylamide, respectively, in gel buffer (3 M Tris and 
0.3% (w/v) SDS, pH 8.45). The separating gel also contained 0.1% glycerol. The 
protein samples were diluted two-fold in sample buffer (12% (w/v) SDS, 6% (v/v) 
β-mercaptoethanol, 30% (w/v) glycerol, 0.05% (w/v) Coomasie Blue and 150 mM 
Tris, pH 7) and then incubated at 37 °C for 30 minutes. The cathode (1 M Tris, 
1 M Tricine and 1% (w/v) SDS; pH 8.25) and anode (1 M Tris; pH 8.9) buffer were 
added to the upper and bottom compartments, respectively, before the protein samples 
were loaded. Initially, 30 V was applied until the samples reached the separating gel, 
followed by 130 V for separation. Standard molecular weight markers were used to 
assess the migration and purity of the wild-type and mutant proteases. 
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2.7 Protein concentration determination  
 
To determine the concentrations of the proteins, the Beer-Lambert law was applied:  
                                                            lεcA =                                              Equation 2 
where A is the absorbance, ε (M-1.cm-1) is the molar extinction coefficient, c (M) is 
the concentration of the sample and l (cm) is the path length of light taken to travel 
through the cuvette.  
 
Since the aromatic residues absorb maximally at 280 nm (Lakowicz, 1983), 
absorbance readings at 280 nm were recorded using a Jasco V-630 UV-Vis 
spectrophotometer. The readings were recorded for 10 serial dilutions of the 
respective protein. The molar absorption coefficient (ε280 nm) of 11800 M-1.cm-1 was 
used for the wild-type and F99A and 6250 M-1.cm-1 for the W42F/F99A (Perkins, 
1986).  
 
2.8 Structural characterisation of wild-type and mutant proteases 
 
It was important to examine the secondary, tertiary and quaternary structural 
modifications, if any, induced by the F99A and/or W42F/F99A.   
 
2.8.1 Secondary structure assessment using far-UV circular dichroism 
 
The inherent ability of proteins to differentially absorb circularly polarised light aids 
in the characterisation of their secondary structure (Woody, 1995). Optical activity is 
observed in amino acids with aromatic and sulfide groups. The amino acid backbone 
also exhibits optical activity, and it is the different organisation of the backbone that 
gives distinct CD spectra for various proteins (Woody, 1995). Absorption range for 
far-UV is between 190 nm and 250 nm. The secondary structural modifications 
induced by the F99A and W42F/F99A were investigated exploiting this technique.  
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The spectral measurements were obtained using a Jasco J-810 spectropolarimeter 
running Spectra Manager with the v1.5.00 software over the wavelength range of 
190 nm to 250 nm. The data were collected at 20 °C using a data pitch of 0.5 nm, 
bandwidth of 0.1 nm and scan speed of 200 nm.min-1. The spectra were an average of 
10 accumulations. All the proteins were prepared to a final concentration of 15 µM in 
a buffer containing 10 mM sodium acetate, 2 mM DTT at pH 5. To avoid 
discrepancies due to protein concentration, the mean residue ellipticity [Θ] 
(deg.cm2.dmol-1.residue-1) was calculated using the equation  
                                                       
lcn
100][ θΘ ×=                                        Equation 3 
where c is the concentration of the protein in mM; l is the path length in cm, n is the 
number of residues in the protein chain and θ is the ellipticity (mdeg).  
 
2.8.2 Tertiary structure assessment using fluorescence spectroscopy 
 
The underlying principles of fluorescence spectroscopy is that a molecule absorbs 
light at a certain wavelength and emits it at a higher wavelength where the energy lost 
between the absorbed and emitted light is referred to as Stokes shift (Lakowicz, 1983) 
This loss in energy is due to interactions between the fluorophore and its immediate 
environment (Lakowicz, 1983). In proteins, aromatic rings of residues such as 
phenylalanine, tyrosine and tryptophan are used as fluorescent probes, but tryptophan 
is the dominant fluorophore. These probes can absorb light at 280 nm; however, the 
indole ring of tryptophan can be exclusively excited at 295 nm. The indole ring of the 
tryptophan makes it very sensitive to the polarity of its environment and was, 
therefore, used as an indicator of any local tertiary structural changes of the mutants 
with respect to the wild-type.  
 
The monomeric HIV-1 protease has two tryptophan residues, W6 and W42. The W6 
is positioned near the dimer interface N-terminal β-strand and W42 is positioned at 
the hinge region of the flaps fully exposed to the solvent, and is within 4 Å of Y59. 
This residue was also mutated to create the W42F/F99A mutant. This was done so 
that changes that might have only occurred at the N- and C-termini antiparallel β-
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sheet accompanying the F99A mutation can be monitored via W6. The W42F/F99A 
mutant has a single tryptophan per monomer, that is, W6 to monitor changes 
occurring only at the dimer interface near the N- and C-termini antiparallel β-sheet. 
 
Fluorescence measurements were performed using Perkin Elmer LS 50 B 
Luminescence fluorimeter. The spectra were recorded as an average of 5 
accumulations at a wavelength range of 280 nm to 450 nm at 20 °C. The scan speed 
of 200 nm.min-1 was used. The same protein samples prepared for far-UV CD 
spectroscopy (section 2.8.1) were used for this experiment. 
 
2.8.3 Quaternary structure assessment using SE-HPLC coupled with DLS 
 
To assess the molecular weight and hydrodynamic volume of the purified protease 
size-exclusion high performance liquid chromatography (SE-HPLC) coupled with 
dynamic light scattering was used. In this technique, proteins with smaller 
hydrodynamic volume get trapped within the column beads and are retained longer.  
 
The HPLC has a Bio-Select SEC matrix with a resolution of 5 to 250 kDa (BIO-RAD, 
South Africa). The experimental procedures were carried out at a constant flow-rate 
of 1 ml.min-1 with an isocratic pressure of 65 bar. The temperature was kept constant 
at 20 °C. The protease was first dialysed against a buffer containing 10 mM sodium 
acetate, 1 mM NaCl and 2 mM DTT, pH 5 (protease storage buffer). The protease was 
then filtered before loading to the HPLC column. The buffer used for protease dialysis 
was used to equilibrate the HPLC matrix. The buffers were de-gassed and filtered 
before use. 
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2.8.4 ANS binding studies to native and unfolded wild-type versus the F99A and 
W42F/F99A proteases 
 
Further assessment of the quaternary structure was carried out using an extrinsic 
fluorescent probe, ANS (8-anilino-1-naphthalene sulfonate). ANS is an anionic dye 
that can be used to probe hydrophobic patches on a protein.  
 
 
In its unbound form, when ANS is excited at 390 nm, it emits light at 540 nm 
(Semisotnov and Gilmanshin, 1991). When this fluorescent dye binds to accessible 
hydrophobic patches it undergoes a hypsochromic shift to a wavelength of 460 nm 
with a simultaneous hyperchromic shift. 
 
The ANS was prepared to a final concentration of 2 mM in buffer containing 20 mM 
sodium phosphate, 0.01% sodium azide and 2 mM DTT. The concentration of ANS 
was confirmed by using the extinction coefficient ε350 nm = 4 950 M-1.cm-1. The protein 
assays were prepared to a final concentration of 15 µM and incubated for 2 hours with 
ANS which was added to a final concentration of 200 µM. For the unfolded protease 
assays, the proteins were prepared to a final concentration of 15 µM in 8 M urea. The 
proteins were incubated in the urea overnight at 20 °C. The spectral measurements 
were recorded using a Perkin Elmer LS 50 B Luminescence fluorimeter. 
 
2.9 Thermal unfolding of the wild-type, F99A and W42F/F99A proteases 
 
The thermal stability of a protein is defined by the Gibbs free energy difference 
between the folded and unfolded protein where 
  
                                                       F
o
U
o GGG −=∆                                     Equation 4 
 
Thermal unfolding can be monitored via differential scanning calorimetry or, in this 
case, by circular dichroism spectroscopy. Conformational changes are observed 
simultaneously with an increase in temperature applied to the protein sample.  
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The experimental parameters that can be extracted are the melting temperature (Tm), 
change enthalpy (∆H(Tm)) which are used to determine the stability (∆G(T)). But, this 
can only be true if the unfolding transition is thermodynamically reversible (Pace, 
1986). The reversibility is frequently impeded by aggregation of the heat-unfolded 
polypeptide. The aggregation can be monitored or is represented by changes in the 
voltage (Benjwal et al., 2006). 
 
 
The thermal unfolding of the HIV-1 protease was monitored at a wavelength of 
230 nm. A local maximum was observed for the CD spectra of the native wild-type 
whereas the mutants had a negative ellipticity at 230 nm. The wild-type, F99A and 
W42F/F99A samples were prepared to a final concentration of 30 µM in the protease 
storage buffer. Unfolding was monitored at a temperature range from 20 °C and 
100 °C. The rate of the temperature increase was set at 1 °C/min and to control the 
temperature the Jasco PTC-423S Peltier-type temperature control system was used. 
 
2.10 Functionality of the proteases 
 
A chromogenic substrate, which is an analogue of the conserved cleavage site 
between the capsid protein (CA) and nucleocapsid (p2) in the Gag polyprotein 
precursor, was used for the activity studies. The substrate is a synthetic peptide with 
the amino acid sequence Lys-Ala-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle-NH2. The 
aromatic -p-nitro-Phe moiety is largely responsible for absorption at 300 nm hence 
cleavage/removal of the p-nitro- from the phenyl ring causes decrease in absorbance 
at this wavelength.  
 
The specific activity, which gives an indication of the amount of pure/functional 
enzyme, was calculated by plotting the initial velocity versus the amount of protein. 
The buffer contained 50 mM sodium acetate, 0.1 M sodium chloride, pH 5 for all the 
experiments. The substrate concentration was kept constant at 50 µM while the 
enzyme concentration was varied between the range 0.1 µM to 0.26 µM (wild-type) 
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and 1.8 µM to 3 µM (F99A). In order to compute the maximum velocity (Vmax) and 
the substrate binding affinity (KM), the Michaelis-Menten equation was used: 
 
                                        
m0
0max
0 ][
][
KS
SVV
+
=                                                     Equation 5                
                                                 
 
where the V0 is the initial velocity and [S0] is the initial substrate concentration.  
 
 
The wild-type and F99A assays included varied substrate concentrations between 
40 µM and 300 µM and the enzyme concentration was kept constant either at 
0.240 µM or 2 µM. The V0 was recorded over 60 seconds of the initial rate of the 
reaction. When the enzyme concentration is much higher than the Km: 
 
       tcatmax ][EkV =                                                   Equation 6 
 
where the [E]t is the total concentration of enzyme and kcat is the turn-over number. 
The turn-over number is the amount of substrate converted into product per active site 
per second and is determined from the slope of the initial velocities versus the enzyme 
concentration.  
 
All assays were performed at 20 °C and data were collected using a Jasco V-630 
spectrophotometer at a wavelength of 300 nm (Velazquez-Campoy et al., 2001b). In 
order to convert the absorbance to reaction rates, the substrate extinction coefficient 
of 1800 M-1.cm-1 was used. The effects of the introduced mutation on the functionality 
of the protease were analysed and compared to the wild-type. The data was fitted 
using Sigma Plot v.11 software (Systat software).  
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Chapter 3 Results 
3.1 Multiple sequence and secondary structural alignments 
 
To probe conserved residues at the dimer interface of the protease, multiple sequence 
alignments were performed using Clustalw2 (Larkin et al., 2007). The conserved 
residues were identified from a set of aligned amino acid sequences which represented 
the respective HIV-1 subtypes (Figure 8). Ultimately, all the residues comprising the 
N- and C-termini antiparallel β-sheet were conserved. This region was also found to 
be structurally conserved across subtype A, C-SA and even in the drug resistant 
subtype B protease (Figure 8). To investigate if the N- and C-termini antiparallel β-
sheet was also structurally conserved, the selected structures were superimposed using 
the computational tool, PyMOL (DeLano Scientific, 2006).  
 
3.2 Sequence verification of DNA insert 
 
The pET-WTCSA, pET-F99A-CSA and pET-W42F/F99A-CSA encode HIV-1 
subtype C protease wild-type, F99A and W42F/F99A mutants, respectively. These 
inserts were sequenced using the universal T7 primers at Inqaba Biotec (South Africa) 
in order to verify the nucleotide sequence of the DNA. The desired mutations were 
incorporated (Figure 9 and 10) in the insert DNA. The wild-type and variant DNA 
sequences retrieved from the sequencing results were further translated into their 
amino acid sequence using ExPasy translation tool (University of Geneva, 
Switzerland) to verify and compare the wild-type and mutants. A short upstream 
sequence (Figure 11), which coincides with the autoprocessing site also present in or 
mimicking the p6-protease cleavage site (Wan et al., 1996), was present in the wild-
type and mutant constructs. It is, therefore, essential that during heterologous 
expression of the protease that auto-cleavage occurs for complete activity of the 
enzyme.   
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Figure 8. Multiple sequence and structural alignment of different HIV-1 
protease subtypes 
(A) The segment representing the N- and C-termini residues (red) are indicated. The 
asterisks represent conserved residues. Double and single dots represent residues 
which show conserved and semi-conserved substitutions, respectively. The omitted 
residues are represented by dashed lines. The image was generated using Clustalw2 
(Larkin et al., 2007). (B) Structural alignment of HIV-1 subtype A (green), subtype C 
SA (pink) and subtype B drug resistant (blue) proteases with PDB codes 3IX0 
(Robbins et al., 2010), 3U71 (Naicker, P. et al., unpublished data) and 1RPI (Logsdon 
et al., 2004), respectively.  
 
 
 
 
 
 
 
 
       N-                      -C 
(Subtype A)        1 PQITLWQRPL-----LTQLGCTLNF 99 
(Subtype B)        1 PQITLWQRPL-----LTQLGCTLNF 99 
(Subtype C,Indian) 1 PQITLWKRPL-----LTQLGCTLNF 99 
(Subtype C, SA)    1 PQITLWQRPL-----LPQIGCTLNF 99 
(Subtype D)        1 PQITLWQRPL-----LTQIGCTLNF 99 
(Subtype F)        1 PQITLWKRPL-----LTQIGCTLNF 99            
Drug resistant     1 PQITLWQRPI-----MTQIGCTLNF 99 
                     ******:**:-----:.*:******  
                              
N- 
C- 
C- 
N- 
A 
B 
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Figure 9. Segments from sequenced HIV-1 subtype C wild-type and F99A insert 
DNA 
The pET-WT-CSA (A) and pET-F99A-CSA (B) chromatographs are represented. The 
phenylalanine codon (dotted box) in the wild-type was replaced by an alanine (solid 
box) yielding the F99A mutant. Images were generated using Finch T.V version 1.4.0. 
The sequencing data was received from Inqaba Biotec (South Africa). 
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Figure 10. Sections from sequenced HIV-1 subtype C wild-type and W42F/F99A 
insert DNA 
The mutated codons are highlighted in the pET-WT-CSA (A) and pET-W42F/F99A-
CSA (B). The W42 (dotted box) and F99 (solid box) codons in the wild-type were 
replaced by phenylalanine (dotted circle) and alanine (solid circle) codons yielding 
the W42F/F99A mutant. The images were generated using Finch T.V version 1.4.0. 
The sequencing data was received from Inqaba Biotec (South Africa). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
 
B 
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Figure 11.  Amino acid sequences of the wild-type, F99A and W42F/F99A cDNA  
A decapeptide (green) upstream of the first residue (brown) making up the 99 amino 
acid residues of the mature protease were identified in all the proteins. The Q7K 
(pink) mutation was also confirmed in the proteases. The desired mutations at the 
W42 (red) and F99 (purple) positions were confirmed by comparison to the wild-type 
sequence. Conserved residues are indicated by asterisks, substitutions are shown by a 
single dot. The ExPasy (University of Geneva, Switzerland) translation tool was used. 
The Clustalw2 (Larkin et al., 2007) was used for the alignment. 
 
 
 
 
 
 
 
 
 
Wild-type DRQGTVSFNFPQITLWKRPLVSIKVGGQIKEALLDTGADDTVLEEINLPGKWKPKME 47   
                                                                                                                       
F99A      DRQGTVSFNFPQITLWKRPLVSIKVGGQIKEALLDTGADDTVLEEINLPGKWKPKME 47 
                                                                                                                      
W42F/F99A DRQGTVSFNFPQITLWKRPLVSIKVGGQIKEALLDTGADDTVLEEINLPGKFKPKME 47 
                                                                                                             
          ***************************************************.*****              
  
                                                                                                            
Wild-type TIGGIGGFIKVRQYDQILIEICGKKAIGTVLVGPTPVNIIGRNMETLTQLGCTLNF 99 
                                                                                                                      
F99A      TIGGIGGFIKVRQYDQILIEICGKKAIGTVLVGPTPVNIIGRNMETLTQLGCTLNA 99 
                                                                                                                      
W42F/F99A TIGGIGGFIKVRQYDQILIEICGKKAIGTVLVGPTPVNIIGRNMETLTQLGCTLNA 99 
                                                                                                                      
          *******************************************************. 
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3.3 Over-expression and purification of the wild-type, F99A and W42F/F99A 
 
The wild-type, F99A and W42F/F99A proteases were over-expressed in Escherichia 
coli T7 Express cells as inclusion bodies and purified under the same set of 
conditions. The wild-type had a lower expression yield of about 1.25 mg, while the 
proteases encoding F99A and W42F/F99A, yielded about 16 mg per litre of culture. 
The differences in concentration were determined spectrophotometrically at A280 
using the Beer-Lambert law. Tricine SDS-PAGE evaluation indicated that all the 
proteins were purified to homogeneity as depicted by the single bands corresponding 
to each protein (Figure 12). The wild-type shows a sharper band while the mutants’ 
migration resulted in smearing. The wild-type and both the F99A and W42F/F99A 
bands correspond to relative molecular weights of 11 kDa and 7 kDa, respectively. 
These results were observed with every purification analysis via tricine SDS-PAGE.  
The wild-type corresponds to the expected HIV-1 protease monomeric molecular 
weight (Ido et al., 1991). The estimated molecular weight for the variants is not 
reliable since it falls outside the range of the standard molecular weight markers. The 
wild-type and the mutants have the same pI value of 9.32 (ExPasy tools). It is known 
that the pI of a protein can interfere with SDS binding hence causing anomalous 
migration on the SDS-PAGE (Pitt-Rivers and Impiombato, 1968). Therefore the 
anomalous migration of the mutants may not be attributed to changes in the pI. 
Further investigations could be done in future to assess the cause of the differences in 
migration of the wild-type and variants. 
 
3.4 Secondary structure analysis of F99A, W42F/F99A and wild-type 
 
The secondary structural properties of the wild-type, F99A and W42F/F99A were 
analysed by far-UV circular dichroism spectroscopy. The wild-type spectrum showed 
a minimum at 214 nm and a local maximum at 230 nm. The minimum is typical of 
predominantly β-sheeted proteins and the local maximum has also been observed in 
the literature (Woody, 1995; Noel et al., 2009). This, however, is not the case with 
F99A and W42F/F99A which exhibit minima at 203 nm, and do not portray the local 
maximum observed for the wild-type at 230 nm (Figure 13).  
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Figure 12. Molecular weight determination using tricine SDS-PAGE of purified 
proteases  
The wild-type, F99A, W42F/F99A and a standard molecular weight marker are 
indicated in their respective lanes. The proteins were all prepared under reducing 
conditions. Standard protein molecular weight marker was used to construct the 
calibration curve. The distance that the proteins migrated and the corresponding 
molecular weight are indicated on the calibration curve. The curve’s regression 
equation is y = - 1.724 x + 2.048 with the correlation coefficient of 0.99.  
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Figure 13. Far-UV circular dichroism spectra of native HIV-1 subtype C 
proteases  
The spectra are a representation of secondary structural elements of native wild-type 
(●), F99A (●) and W42F/F99A (●). The arrows indicate wavelengths of 203 nm 
(solid), 214 nm (dotted) and 230 nm (dashed). The proteins were prepared to a final 
concentration of 15 µM in 10 mM sodium acetate buffer, pH 5. The blanks were 
subtracted from the raw data.   
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3.5 Tertiary structure analysis of F99A, W42F/F99A and wild-type 
 
In order to probe tertiary structural changes, if any, intrinsic fluorescence 
spectroscopy was used. This technique allows the use of phenylalanine, tyrosine and 
tryptophan residues, but relies mainly on the fluorescence properties of the tryptophan 
indole with respect to its local environment. The wild-type HIV-1 protease has a 
single tyrosine (Y59) and two tryptophan residues (W6 and W42) per monomer. 
Excitation at a wavelength of 280 nm (tryptophan and tyrosine excitation) showed the 
emission of the wild-type at 355 nm and of both the mutants at 357 nm (Figure 14). 
The 2 nm red-shift was consistent, occurring after every round of purification. The 
fluorescence intensity of the mutants was about 50% higher than that of wild-type. 
The emission wavelength following excitation at 295 nm (tryptophan excitation) was 
355, 356 and 357 nm for wild-type, F99A and W42F/F99A, respectively (Figure 15). 
The 2 nm red-shift is also observed with excitation of the lone tryptophan residue 
(W6) positioned at the N- and C-termini antiparallel β-sheet. Although a 2 nm shift 
may be small, but the consistency of this result may indicate that there are tertiary 
structural changes occurring at this region.  
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Figure 14. Fluorescence spectra of HIV-1 subtype C proteases with excitation at 
280 nm 
The emission spectra of the wild-type (●), F99A (●) and W42F/F99A (●) in their 
native forms are indicated above. Tyrosine and tryptophan residues were excited at 
280 nm to give an indication of tertiary structural differences of the proteins. The 
proteins were prepared to a final concentration of 15 µM in 10 mM sodium acetate 
buffer, pH 5. The blanks were subtracted from the raw data.   
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Figure 15. Tryptophan emission spectra of wild-type, F99A and W42F/F99A 
proteases 
The tryptophan emission spectra of native wild-type (●), F99A (●) and 
W42F/F99A (●).The tryptophan residues were exclusively excited at a wavelength of 
295 nm. The proteins were prepared to a final concentration of 15 µM in 10 mM 
sodium acetate buffer, pH 5. The blanks were subtracted from the raw data.   
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3.6 Extrinsic ANS-binding fluorescence 
 
The fluorescent dye, ANS (8-anilino-1-naphthalene sulfonate) binds to exposed 
hydrophobic patches of a protein, and consequently, the emission wavelength is blue 
shifted with an increase in the quantum yield (Semisotnov and Gilmanshin, 1991).  In 
the presence of the native forms of the wild-type, F99A and W42F/F99A the quantum 
yield increased from 40 to 46% and there is a blue shift to 480 nm compared to free 
ANS, which emitted light at a wavelength of 510 nm. The unfolded protein and free 
ANS emission spectra are red shifted with the quantum yield of the free ANS slightly 
higher (Figure 16).  
 
3.7 Analysis of molecular weight and hydrodynamic volume of wild-type, F99A 
and W42F/F99A 
 
Size-exclusion HPLC was employed to compare the hydrodynamic volume and 
molecular weight of the mutants to that of the wild-type (Figure 17). There are two 
clear peaks for the wild-type and W42F/F99A. The F99A had a single peak with 
‘shoulders’. Distinct peaks in Figure 17 suggest different oligomeric states, thus 
indicating that both dimeric and monomeric species exist in the protein sample. The 
retention times of the dominant peaks for the wild-type, F99A and W42F/F99A 
corresponds to 16.4 kDa, 20.7 kDa and 18.1 kDa, respectively. Differences in the 
elution profiles and molecular weight of the wild-type versus the mutants imply that 
the F99A mutation could have caused a shift in monomer-dimer equilibrium. The 
expected relative molecular weight, for the wild-type is 22 kDa. This suggests that the 
protein behaves anomalously on this HPLC matrix. It is possible that the proteins may 
be interacting with the matrix causing retardation in the movement of the proteins 
through the matrix and thus increasing their retention time. Nonetheless there is an 
observed slight increase in the hydrodynamic volume of the mutants. 
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Figure 16. Comparisons of ANS binding to wild-type, F99A and W42F/F99A  
ANS binding to native wild-type (●), F99A (●) and W42F/F99A (●) and unfolded  
forms of the wild-type (○), F99A (○) and W42F/F99A (○). The solid line represents 
free ANS. The arrows indicate the shift in wavelength where the maximum 
fluorescence intensity is observed. The wild-type and variant proteases were prepared 
in 10 mM sodium acetate buffer, pH 5 to final concentrations of 15 µM. The ANS 
was added to a final concentration of 200 µM. 
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Figure 17. SE-HPLC of the wild-type, F99A and W42F/F99A  
(A) The SE-HPLC elution peaks for the wild-type (3 and 4), F99A (1) and 
W42F/F99A (2 and 5). The flow rate was at 1 ml/min at an isocratic pressure of 
65 bar for all the proteins. The equilibration buffer used 10 mM sodium acetate, 
1 mM NaCl and 2 mM DTT, pH 5 (B) Standard curve includes: thyroglobulin 
(670 kDa), γ-globulin (158 kDa), ovalbumin (44 kDa), myoglobin (17 kDa) and 
vitamin B12 (1.35 kDa). The standards and profile peak points are indicated by 
symbols ○ and ●, respectively. The equation for the curve is y = - 0.321 x + 4.931 and 
correlation coefficient, 0.98. 
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3.8 Thermally-induced unfolding of wild-type, F99A and W42F/F99A proteases 
 
The thermal unfolding of the HIV-1 proteases was monitored at a wavelength of 
230 nm where the differences in the local maximum was observed between circular 
dichroism spectra of the native wild-type, F99A and W42F/F99A. The thermal 
unfolding was monitored at 230 nm, which is mainly indicative of the polypeptide 
backbone conformation and is also postulated to be due to exciton coupling between 
W42 and Y59 (Noel et al., 2009).  The unfolding was irreversible since there was an 
increase in turbidity concomitant with a large increase in wild-type unfolding at the 
same temperature (Figure 18). The wild-type shows a more defined unfolding 
transition between 55 °C and 63 °C in contrast to the two variants. There is an 
obvious overlap of the folded/native states (between 20 °C and 55 °C) of the wild-
type, F99A and W42F/F99A but the unfolded transition of the variants seems to 
approach that of the wild-type, but does not overlap with it even at 100 °C.  
 
3.9 Effects of F99A mutation on the catalytic activity of the protease  
 
Evidence from the secondary structural changes observed as a result of the F99A 
mutation led to the postulation that it might have an adverse effect on the functionality 
of the protease. The assay is based on the ability of the protease to hydrolyse the 
chromogenic substrate, Lys-Ala-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle-NH2. This 
substrate mimics the conserved cleavage site between the capsid (CA) and 
nucleocapsid (p2) in the Gag precursor with the sequence (Velazquez-Campoy et al., 
2001a; Mosebi et al., 2008). The first 60 seconds of the reaction fitted the linear 
relationship typical of progress curves. It is important to note that the F99A displayed 
higher levels of noise to signal ratio compared to the wild-type at enzyme 
concentrations below 1.8 µM. To generate reproducible data from the assays done in 
triplicate higher enzyme concentrations had to be used. The specific activity of the 
wild-type was 1.5 µmol/min/mg and that of the F99A was significantly reduced to 
0.13 µmol/min/mg, which amounts to a ten-fold decrease (Figure 19). Although the 
substrate binding affinity (KM) of the F99A was slightly increased, the Vmax and kcat 
were significantly higher for the wild-type (Figures 20, 21 and 22).  
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The catalytic profile of the wild-type and F99A are summarised in Table 2. These 
results are comparable with previous studies (Mosebi et al., 2008). 
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Figure 18. Thermal unfolding of the wild-type, F99A and W42F/F99A 
The thermal unfolding of the wild-type (red), F99A (black) and W42F/F99A (blue) 
were analysed by circular dichroism. The unfolding (A) and turbidity (B) were 
monitored at a wavelength of 230 nm between 20 °C and 100 °C. The bandwidth was 
set at 1 nm and the data pitch was 0.2 °C. The proteins were each prepared to a final 
concentration of 15 µM in buffer containing 10 mM sodium acetate, 2 mM DTT, 
pH 5.  
 
Temperature (oC)
20 40 60 80 100
H
T 
(vo
lts
)
330
335
340
345
350
355
360
 
B 
Temperature (oC)
20 40 60 80 100
M
ea
n
 
re
sid
u
e 
el
lip
tic
ity
 
a
t 2
30
 
n
m
 
(d
eg
.
cm
2 .
dm
o
l-1
) 
-350
-300
-250
-200
-150
 
A 
 48 
 
Figure 19. Specific activity of wild-type and F99A HIV-1 subtype C proteases 
The specific activity of the wild-type (●) and F99A (○) were computed from the slope 
of the graphs to be 1.5± 6.3×10-4 µmol/min/mg and 0.13± 5.31×10-3 µmol/min/mg, 
respectively. The assays were performed in triplicate and data is reported as mean ± 
SE. The assays were performed at 20 °C in 50 mM sodium acetate, 0.1 M NaCl, pH 5. 
The reactions were initiated with 50 µM substrate in varying protease concentration 
range of 0.4 to 4.2 µM and 1.8 to 3 µM for the wild-type and F99A, respectively. The 
reactions were monitored at a wavelength of 300 nm. The correlation coefficient is 
0.97 for both graphs.  
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Figure 20. Determination of the Michaelis-Menten constants and maximum 
velocities of the wild-type and F99A proteases using 2 µM of enzyme 
The wild-type (●) and F99A (○) were found to have KM values of 166.3± 6.6 µM and 
98.0± 3.9 µM, respectively. The F99A had a Vmax of 0.003± 6.32×10-5 µmol/min and 
that of the wild-type was of 0.08± 1.47 × 10-3 µmol/min. The wild-type and F99A 
protease concentration were kept constant at 2 µM with the substrate concentration 
varied between 40 and 300 µM. The assays were conducted at 20 °C in 50 mM 
sodium acetate, 0.1 M NaCl, pH 5. The reactions were monitored at 300 nm. The 
correlation coefficient of the wild-type and F99A plots are 0.99 and 0.98, 
respectively. The assays were performed in triplicate and data is reported as mean ± 
SE. 
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Figure 21. Michaelis-Menten constant and maximum velocity determination of 
the wild-type and F99A using 0.24 µM enzyme 
The KM for the wild-type (●) and F99A (○) had comparable values of 166.9±5.54 µM 
and 143.6±1.7 µM, respectively. The Vmax for the wild-type were determined to be 
0.023±3.95×10-4 µmol/min and that of the F99A was 0.003±9.68×10-5 µmol/min. The 
reactions were monitored at a wavelength of 300 nm. The assays were performed at 
20 °C in 50 mM sodium acetate, 0.1 M NaCl, pH 5. Each assay was done in triplicate. 
The reactions were monitored at a wavelength of 300 nm. The correlation coefficient 
of the wild-type and F99A plots are 0.99 and 0.97, respectively. The assays were 
performed in triplicates and data is reported as mean ± SE. 
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Figure 22. Turn-over determination of the wild-type and F99A proteases 
The amount of substrate converted to product per active site (or turn over number or 
kcat) was calculated from the slopes of the linear curves. The wild-type (●) and F99A 
(○) kcat were found to be 1.04±0.23×10-1 sec-1 and 0.51±0.0215 sec-1, respectively. 
Experiments were done at 20 °C in 50 mM sodium acetate, 0.1 M NaCl, pH 5. The 
protease concentrations were varied between 0.1 to 0.3 µM while the substrate was 
kept constant at 250 µM. Each reaction was done in triplicate and monitored at 
300 nm. The data is reported as mean ± SE. 
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Table 2: Catalytic profiles of the wild-type and F99A 
The catalytic parameters of the wild-type and F99A were computed and summarised 
below: 
 
Enzyme concentration (µM) Parameter Wild-type F99A 
 
Specific activity 
(µmol/min/mg) 1.5 0.13 
 kcat (sec-1) 1.04 0.51 
                     2  KM (µM) 166.3 98.0  
 VMAX  (µmol/min) 0.08 0.003 
                  0.24   KM (µM) 166.9 143.6 
 
VMAX  (µmol/min) 0.023 0.003 
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CHAPTER 4 DISCUSSION 
 
The C-terminal residue, F99, is conserved across the HIV-1 protease subtypes 
including drug resistant strains. The bulky, hydrophobic ring of this residue was 
replaced with the smaller side-chain of alanine to create a cavity (Figures 23 and 24) 
within the hydrophobic cleft around the F99. The mutation could also disrupt the 
‘lock-and-key’ motif formed by the F99 and the residues forming the hydrophobic 
cleft (Figure 6). Engineering of the F99A and W42F/F99A mutations was successful 
and this was confirmed by Inqaba Biotec sequencing results. The wild-type, F99A and 
W42F/F99A possess a short peptide upstream (Figure 11) of the protease amino acid 
sequence. This short upstream peptide mimics the transframe/protease (TF/PR) 
cleavage site and has been shown to be crucial for the HIV-1 protease self-processing 
during heterologous expression in E. coli cells (Hostomsky et al., 1989; Valverde et 
al., 1992). The F99A and W42F/F99A showed much higher expression yield 
compared to the wild-type under the same conditions. A decrease in the catalytic 
activity accompanying the F99A mutation could have caused the enzyme to be less 
toxic to the E. coli cells (Hostomsky et al., 1989; Miroux and Walker, 1996; Dumon-
Seignovert et al., 2004). The role of this residue in the structure, function and thermal 
stability of the HIV-1 subtype C protease was investigated.  
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Figure 23 Global view of the F99 position and cavity formed by F99A mutation 
in the HIV-1 protease 
Each subunit is represented by the ribbon structure coloured blue and green, 
respectively. The wild-type (A) contains the phenyl ring of F99 while in the F99A (B) 
the phenyl ring is replaced by cavities (grey) in each subunit. The symmetrical axis is 
indicated by the dashed lines. Image was generated using PyMOL v0.99 (DeLano 
Scientific, 2006). PDB code 3U71 (Naicker, P. et al., unpublished data). 
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Figure 24. Simulation of the cavity created by substituting phenylalanine with 
alanine.  
The molecular surface area around the (A) F99 and (B) A99 residues is indicated by 
circles. The pocket occupied by the phenyl ring may be replaced by water molecules 
in the F99A hence the bulging of the surface area. The green and blue represent the 
surface area computed for the respective subunits. Image generated using PyMOL 
v0.99 (DeLano Scientific, 2006). PDB code 2R5Q (Coman et al., 2008b). 
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4.1 Role of F99 on the structure of HIV-1 subtype C protease 
 
The W42F/F99A mutation was created so that tertiary structural changes that have 
occurred at the N- and C-termini antiparallel β-sheet region can be monitored 
exclusively. The W42 is solvent exposed, thus, the indole ring does not form any 
hydrogen bonds (Swiss-pdb Viewer) with any core residues which could be essential 
for maintaining the native structure of the protease. The bulky side chain of 
tryptophan was replaced with an equally, but non-fluorescent, bulky phenylalanine. 
This was done to compensate for the van der Waals interactions that the W42 side 
chain makes with neighbouring residues in its native wild-type conformation. Thus, 
any structural changes observed for the W42F/F99A mutant should be due to the 
F99A mutation.  
 
4.1.1 Secondary structural characterisation 
 
The wild-type, F99A and W42F/F99A were prepared to the same final concentrations 
following dialysis against DTT-containing buffer to avoid oxidation of 
sulfur-containing residues. The HIV protease contains two cysteine residues, C67 and 
C95 per monomer. The C95 residue is located at the dimer interface and its oxidation 
causes the inhibition of protease catalytic activity by preventing dimerisation (Davis 
et al., 2003). The proteins were monitored under the same set of parameters. The 
same results were obtained following every round of purification.  
 
The observed trough at 203 nm implies that the engineered F99A mutation caused a 
decrease but not complete loss in β-sheet content. It is possible that this loss is 
localised at the N- and C-termini β-sheet since this is where the mutation was 
engineered. Synthetic homopolypeptides are often used as models for the basic 
characterisation of the ‘pure’ spectra of α-helices, β-sheets and random coils (Pauling 
and Corey, 1951; Manning et al., 1988; Bannister and Bannister, 1974). In contrast to 
proteins, homopolypeptides form longer chained α-helices and β-sheets and the 
random coils are extended. This poses a complexity when analysing the more 
complicated structures of globular proteins.  
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Therefore, different wavelengths often assigned to a single structural element, might 
in fact be more multifaceted (Manning et al., 1988; Bannister and Bannister, 1974). 
Using PyMOL as a simulation tool (Figures 23 and 24), this mutation leaves a cavity 
within the N- and C-termini antiparallel β-sheet resulting in loss of inter-monomeric 
van der Waals interactions with the highly conserved C67 (Coman et al., 2008b). This 
presumed perturbation could have diminished the anchoring force between the loop 
where C67 is positioned and the N- and C-termini antiparallel β-sheet, making these 
regions less structured (Figure 25). This could have led to marked untwisting of the β-
sheets perhaps forming random coils, apparent as the negative band at 203 nm. This 
phenomenon has been reported for sheets which are less twisted (Manning et al., 
1988). It has also been shown that increasing the side chain bulk in homopolymers 
increases the twisting of β-sheets (Bannister and Bannister, 1974) Therefore, loss of 
the bulky phenyl ring may have caused disruption of the β-sheets. But, whether these 
changes were local to the N- and C-termini antiparallel β-sheet and if they were 
significant enough to induce the observed spectral shifts can only be deduced 
conclusively with a crystal structure. 
  
Although the aforementioned explanation makes good and valid arguments for the 
significant differences of the far-UV spectra for the wild-type and mutants, the 
contribution of the aromatic amino acids must also be considered. A series of 
phenylalanine mutations at different sites of the bovine pancreatic trypsin inhibitor 
(BPTI) has been previously analysed using far-UV CD (Sreerama et al., 1999). In the 
study, and several others, it was concluded that mutation of an aromatic residue, 
depending on its local environment, can significantly alter the far-UV CD spectra 
(Sreerama et al., 1999; Woody, 1995; Boren et al., 1999; Krittanai and Johnson, 
1997). 
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Figure 25. Local environment around F99 and F99A  
The wild-type F99 (black) and F99A (blue) with the residues that are within 4 Å 
depicted in A and B, respectively. The F99, from the respective chains, was used to 
compute the neighbouring residues. The phenylalanine ring is positioned between 
C67 and C95. Absence of this ring in F99A causes loss of van der Waals inter-
monomer interactions with C67. The prime indicates residues from the paired subunit. 
Hydrogen bonds are shown by dashed lines. Figure generated using PyMOL v0.99 
(DeLano Scientific, 2006) using the PDB code 2R5Q (Coman et al., 2008b)  
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In most cases, the overall arrangement of the backbone of the wild-type and variants 
was similar in the crystal structures. The amount of aromatic side chains coupled with 
their local environment can interfere with secondary structural analysis in the far-UV 
region (Woody, 1994; Boren et al., 1999; Krittanai and Johnson, 1997). Even minute 
modifications in the orientations of the aromatics can cause major differences in CD 
spectra (Boren et al., 1999). In the current study, the F99A mutation might have 
induced local unfolding at the N- and C-termini antiparallel β-sheet perhaps changing 
the environment around the nearby W6 and/or its orientation. This is also an early 
indication that the local environment around the tryptophan(s) has definitely changed 
as a result of the F99A mutation. The loss of an additional aromatic ring in the 
W42F/F99A may explain the slight difference in the mean residue ellipticity 
compared to the F99A (Figure 13). Thus, either the loss of the aromatic phenyl ring 
itself and/or loss of the conserved interactions with the neighbouring residues 
(Figure 25), which might have induced partial unfolding of the protease, could 
account for these results. 
 
The maximum at 230 nm detected in the wild-type far-UV spectra is postulated to be 
due to exciton coupling between W42 and Y59 which are about 3.4 Å apart (Sreerama 
et al., 1999; Noel et al., 2009). The F99 is positioned approximately 34 Å to 39 Å 
from the postulated exciton coupling in the same monomer and 25 Å to 31 Å in the 
other monomer. So, it is plausible that the effects of F99 are also global causing the 
hinge region to be less ordered making the W42 and Y59 less prone to contact and 
diminishing the chances of the exciton coupling. This maximum has also been 
attributed to exciton coupling between an aromatic transition and amide transition 
(Siezen and Argos, 1983). Therefore, either the F99A has induced local unfolding at 
the N- and C-termini antiparallel β-sheet only, or its unfolding effects were also 
global by perturbing the presumed W42 and Y59 exciton coupling. This perturbation 
is represented by absence of the local maxima at 230 nm for the mutant proteases. 
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4.1.2 Tertiary structural characterisation 
 
Fluorescence spectroscopy was used as a technique for comparing the tertiary 
structure of the wild-type and mutants. The fluorescence of tryptophan and tyrosine 
residues as well as their location was used as probes. The samples that were used for 
the far-UV CD analysis were not discarded but were used for fluorescence 
spectroscopy analysis. This was done to eliminate any discrepancies due to sample 
preparation and protein concentration between the CD and fluorescence data. A 2 nm 
red shift is observed after every round of purification. This suggests that the 
tryptophan(s), being the major probes, may be slightly solvent exposed. Also, 
inferring from the loss of the secondary structure, the protease native structure may 
have become less compact especially at the N- and C-termini antiparallel β-sheet 
exposing the W6 residue to the solvent. But why do the mutants have a higher 
intensity versus the wild-type and why do they overlay?  
 
The lower fluorescence intensity exhibited by the wild-type may be due to tryptophan 
fluorescence quenching. There are several factors that influence the quantum yield but 
is a poorly understood concept (Lakowicz, 1983). Fluorescence quenching of 
tryptophan depends on the chemical nature of its neighbouring residues. In its excited 
state, the indole ring can be quenched by a nearby aromatic, proton from a charged 
amino group, electron acceptors such as protonated carboxyl group and electron 
transfer from disulfides, amides or protein backbone (Lakowicz, 1983). The W42 and 
W6 residues in the wild-type are located such that they make van der Waals contacts 
with neighbouring amino acids, some of which have been implicated in tryptophan 
fluorescence quenching. These include R41, K43, P44, R57, Q58 and Y59 near the 
W42 and making contact with the W6 residue are T4, L5, Q7, R87, T91 and Q92 
(Figure 26). Thus, there are possible tertiary structural changes that have occurred at 
the N- and C-termini antiparallel β-sheet and hinge region.  
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Figure 26. Illustration of the W6 and W42 neighbouring residues 
 
The symmetrical subunits are represented in blue and green. The fluorescent probes 
W6 and W42, Y59 and F99 are highlighted in pink, orange and black, respectively. 
The residues that are 4 Å of W6 and W42 are depicted in box A and B, respectively. 
Image was generated using PyMOL v0.99 (DeLano Scientific, 2006). PDB code 
2R5Q (Coman et al., 2008b).  
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The lower fluorescence intensity observed for the wild-type when the tyrosine and 
tryptophan residues are excited (Figure 14) may be mainly, due to, fluorescence 
quenching of W6. This residue would be more sensitive to local structural changes at 
N- and C- termini antiparallel β-sheet since it is positioned near this region and also 
the fluorescence spectra of F99A and W42F/F99A overlay/superimpose. The W42 
and W6, which are both present in the wild-type and F99A proteases, were 
exclusively excited, and only W6 in W42F/F99A protease was exclusively excited. 
The W42F/F99A exhibited a 2 nm wavelength red shift compared to the wild-type 
and this confirms the solvent exposure of the W6 suggesting that the local tertiary 
structure at the N- and C-termini antiparallel β-sheet region has been disrupted. The 
intensity difference between the F99A and W42F/F99A, in this case, is due to the 
absence of W42 residue in the W42F/F99A mutant.   
 
4.1.3 Role in quaternary structural characterisation 
 
The HIV-1 protease quaternary structure was assessed with SE-HPLC (Figure 17). 
The relative molecular weight, at least for the wild-type, was anomalous. The wild-
type is 1.3-fold less than the expected/theoretical value for the dimer and 1.5-fold 
larger than the expected value for the monomer. Both the wild-type and F99A were 
active even at concentrations that were 60-fold lower than the final concentrations 
used for the SE-HPLC experiments. This strongly suggests that the proteins are 
dimeric. Also the wild-type enzyme kinetic parameters are comparable to previous 
studies for the wild-type dimer (Mosebi et al., 2008; Mpye, 2010). There is still 
evidence of an altered hydrodynamic volume exhibited by the mutants. The mutants 
might be slightly less compact than the wild-type suggesting that the F99A might 
have caused ‘partial’ unfolding at the N- and C-termini antiparallel β-sheet. However, 
it is not obvious using only this technique to assert if the exposed residues, if any, are 
hydrophobic or polar.   
 
When ANS binds to hydrophobic patches it displays higher fluorescence intensity and 
a blue shift (Stryer, 1968; Xie et al., 1999). This property of the ANS was used in 
probing if there were any exposed hydrophobic patches accompanying the F99A 
mutation.  
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But, it has also been shown that the sulfonic group of ANS can bind to positively 
charged residues of a protein. This also leads to enhanced fluorescence intensity 
(Matulis and Lovrien, 1998; Andujar-Sanchez et al., 2011). The native and urea-
unfolded forms of the wild-type and mutants were incubated with ANS. The native 
forms of the wild-type and mutants both bind ANS displaying similar fluorescence 
intensities. In contrast, when they are in the denatured state, binding is not observed. 
In fact, others showed competitive binding between ANS and acetyl pepstatin 
implying that ANS binds to the active site of the protease (Xie et al., 1999). The SE-
HPLC result suggests that dimeric species might still exist in both the F99A and 
W42F/F99A, although some distortion in the shape is evident. If the ANS does bind at 
the dimer interface, this further confirms that the dimer is still intact. Therefore, the 
F99 may be crucial during folding and/or dimerisation of the protease to its fully 
folded dimeric form which is required for catalysis.  
 
4.2 Importance of F99 on the thermal stability of HIV-1 subtype C protease 
 
Given that the secondary structure and catalytic profiles of the F99A are different 
from the wild-type, it was imperative to investigate if the stability had been altered. 
The thermal unfolding was monitored at 230 nm, which is mainly indicative of the 
polypeptide backbone conformation and is postulated to be due to exciton coupling 
between W42 and Y59 (Noel et al., 2009). Therefore, unfolding might be largely 
localised at the hinge region. This wavelength has been utilised in other studies to 
monitor unfolding (Arakawa et al., 2001; Noel et al., 2009). It has been shown that at 
this wavelength the effects of solvent absorption are lower than at shorter wavelengths 
(Arakawa et al., 2001). The transition observed at this wavelength is from the n-π* 
transitions of the amide peptide bond (Siezen and Argos, 1983).  
 
The wild-type shows a more defined transition-state in contrast to the mutants. This 
implies that, unlike with the mutants, an increase in temperature changes the 
conformation of the wild-type resulting in a clear difference between species that 
were populated under native versus unfolded conditions.  
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The transition-state of mutants is independent of changes in temperature suggesting 
that there is no free energy barrier between the ensemble of conformations through-
out the melting curve (Naganathan et al., 2005). This suggests that the conformational 
changes that are induced by denaturing conditions may already have occurred before 
thermal denaturation. This is evidence that the same species present at the pre 
transition-state of the mutants is populated through-out the melting curve becoming 
less structured with increase in temperature. Therefore, the transition-state of the 
wild-type is representative of the thermal energy that was required to induce 
conformational change. The urea-induced equilibrium unfolding of the protease 
monitored at this wavelength has been described by a two-state mechanism (Noel et 
al., 2009): U2N2 ⇔ . Therefore, the energy barrier presented by the wild-type 
transition-state may represent the change from the dimeric form to unfolded 
monomers. The less defined transition-state of the mutants may mean that the 
dissociation of monomers may already have been induced by the F99A mutation. 
What could also be happening in the wild-type is that the increase in temperature 
increases distance between the W42 and Y59 by increasing the flexibility of the 
hinges. This would decrease the contact between these residues abolishing the exciton 
coupling as unfolding occurs. The absence of this phenomenon in the mutants means 
the interaction may have already been perturbed by the F99A mutation.  
 
4.3 Effects of the F99A mutation on the catalytic activity of HIV-1 subtype C 
protease 
 
It was important to investigate the catalytic activity of F99A since the F99 is essential 
in maintaining the structural integrity of the protease, hence, it may influence its 
ability to function efficiently. The assays were performed by following cleavage of 
the chromogenic substrate which mimics the in vivo Gag-Pol precursor cleavage site. 
The specific activity was significantly reduced by more than ten-fold when compared 
to that of the wild-type. Interestingly, F99A has a slightly lower KM value of 98.0 µM 
versus 166.3 µM for the wild-type. This implies that the mutant binds the substrate 
slightly tighter. But, the Vmax of F99A has a significantly lower maximum velocity of 
0.0030 µmol/min compared to the wild-type with Vmax of  0.08 µmol/min. The protein 
concentration that was used in this case was 2 µM.  
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When the protein concentration of 0.24 µM was used, the binding affinity was 
comparable. Nonetheless the maximum velocity was ten-fold higher for the wild-type. 
The kcat of the mutant was also compromised as it is 2-fold less than the wild-type. 
The presence of activity in the F99A even at concentrations as low as 0.24 µM proves 
that it is still dimeric.  
   
The peptide mimicking the CA-p2 cleavage site and protease were co-crystallized in a 
study by Prabu-Jeyabalan and colleagues (Prabu-Jeyabalan et al., 2000). It was found 
that the protease makes 24 hydrogen bonds with the substrate and only one direct 
hydrogen bond with the substrate side-chain. This lead to the conclusion that the 
specificity of the HIV-1 protease is mainly attributed to the shape complementarity 
induced upon substrate binding (Prabu-Jeyabalan et al., 2000). There was a loss in the 
secondary structural content and changes in the tertiary and quaternary structure 
accompanying the F99A mutation. Thus, the conformation of the F99A may have 
altered the positioning of residues that are involved in catalysis hence the adverse 
effects on the specific/catalytic activity. Whether these residues interact directly or 
indirectly with the substrate cannot be deduced without a crystal structure.  
 
It was postulated by Singh and colleagues that the HIV-1 protease binds its substrate 
weakly. This is to its advantage because in vivo, the HIV-1 protease is more likely to 
function under high substrate where weak binding lowers the activation barrier, thus, 
increasing its catalytic activity (Singh et al., 2011). The weak substrate binding has 
also been implicated in the so called ‘promiscuity’ of the protein (Singh et al., 2011). 
Tighter binding to substrate may affect catalysis by destabilising the transition-state 
binding thereby lowering the Vmax. This substantiates why the lower KM of F99A 
resulted in a reduced maximum velocity. From the tertiary structural studies it is 
evident that there are slight modifications in the local environment of the W6 and 
W42 of the F99A mutant. The W6 is 3.05 Å and 4.76 Å from the R87 (of second 
subunit) and R8 (in the same subunit), respectively. Co-crystallization of the HIV 
protease and the tetrahedral intermediate showed three water molecules bridging R87 
and R8 to the catalytic triad/residues D25-T26-G27 suggesting they play a role in the 
proper positioning of these catalytic triad/residues during catalysis (Das et al., 2010).  
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The R8 residue makes direct van der Waals interactions with P3 side-chain of the 
peptide which mimics the CA-p2 substrate. Therefore, the change in the W6 local 
environment might have compromised the function of R8 in catalysis possibly by 
changing its position. This, in turn, could have caused a compromise in the 
positioning the catalytic residues and the interaction of R8 with P3 side-chain. The 
W42, on the other hand, is positioned at the hinge region of the flaps. It has been 
established that the hinge controls the flexibility of the flaps (Kozisek et al., 2008; 
Mosebi et al., 2008). The altered W42 environment may have modified the flexibility 
(more likely to have increased the flexibility) at the flaps, increasing the substrate 
binding affinity of the F99A but compromised the catalysis. Although there may be an 
increase in F99A autocleavage, the catalytic activity of the non-precursor-associated 
protease was severely reduced. Others (Pettit et al., 2003) have suggested that in the 
case of the precursor-associated protease the P1 and F99 side-chains cause 
stereochemical hindrance, hence, the alanine smaller side-chain increases cleavage at 
the N-terminus of the protease (Pettit et al., 2003). 
 
4.4 Conclusions 
 
The conserved F99 makes interactions that are crucial for the structural integrity of 
the HIV-1 subtype C protease. These structural modifications have greatly influenced 
catalysis by perturbing the pairing of the N- and C-termini antiparallel β-sheet and in 
turn perturbing dimerisation. This also confirmed the importance of this residue in the 
mechanism of in vitro self-processing which simulates the processing in the host cell. 
The thermal stability of the protein has been compromised and This study has, 
therefore, demonstrated the importance of F99 and its potential role as a target in the 
design of small molecule that inhibit dimerisation at the N- and C-termini antiparallel 
β-sheet.  
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Future work 
The crystal structure and singular value decomposition (SVD) could be used to further 
investigate the secondary structural changes. Urea-induced stability studies could be 
employed to specify and compare the thermodynamic parameters for the wild-type 
and variant proteases. To investigate if the F99A induces changes in the flexibility of 
the protease Thermolysin digestive studies may be used. 
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